APA (7th ed.) Citation

Koliadenko, V., Joly, P., Lemaire, F., Ingen-Housz-Oro, S., Bedane, C., Caux, F., . . . Viguier, M. (2025). Ustekinumab as a potential therapeutic agent in bullous pemphigoid: A biologic and clinical proof-of-concept study. British Journal of Dermatology, 193(6), 1257. https://doi.org/10.1093/bjd/ljaf354

Chicago Style (17th ed.) Citation

Koliadenko, Vlada, et al. "Ustekinumab as a Potential Therapeutic Agent in Bullous Pemphigoid: A Biologic and Clinical Proof-of-concept Study." British Journal of Dermatology 193, no. 6 (2025): 1257. https://doi.org/10.1093/bjd/ljaf354.

MLA (9th ed.) Citation

Koliadenko, Vlada, et al. "Ustekinumab as a Potential Therapeutic Agent in Bullous Pemphigoid: A Biologic and Clinical Proof-of-concept Study." British Journal of Dermatology, vol. 193, no. 6, 2025, p. 1257, https://doi.org/10.1093/bjd/ljaf354.